Results 161 to 170 of about 6,660,147 (290)

Advancing Long‐Term Energy Demand Forecasting: A PRISMA‐Guided Systematic Review of AI and Econometric Models

open access: yesApplied Research, Volume 5, Issue 5, October 2026.
Through a PRISMA‐guided review of 42 studies, this work compares deep learning, ensemble machine learning, and statistical/econometric models for long‐term energy demand forecasting, showing that model choice should balance accuracy, interpretability, data availability, and policy relevance.
Nor Afiza Mohd Noor   +4 more
wiley   +1 more source

Outcomes of adult patients with Li‐Fraumeni syndrome and myeloid neoplasms

open access: yesCancer, Volume 132, Issue 19, 1 October 2026.
Abstract Background Li‐Fraumeni syndrome (LFS) is an inherited cancer predisposition syndrome. Hematologic malignancies are not considered LFS defining tumors, however, both acute lymphoblastic leukemia and therapy‐related myeloid neoplasms (MNs) in LFS are described. Treatment approaches and outcomes of MN in LFS need further evaluation.
Jayastu Senapati   +19 more
wiley   +1 more source

Univariate and multivariate ARIMA versus vector autoregression forecasting [PDF]

open access: yes
The purposes of this study are two: 1) to compare the forecasting abilities of the three methods: univariate autoregressive integrated moving average (ARIMA), multivariate autoregressive integrated moving average (MARIMA), and vector autoregression (both
Michael L. Bagshaw
core  

Examining Test Order Appropriateness Using Mean Abnormal Result Rate in Inpatient and Outpatient Care: A Retrospective Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background and Aims Patients may experience more stress and the healthcare system may incur greater expenditures as a result of doctors ordering too many tests. In order to assess the suitability of testing, the Mean Abnormal Result Rate (MARR) metric—defined as the percentage of tests having abnormal results—was created. Data on how the COVID‐
Parastou Gorovanchi   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy